Versant Capital Management
COGT icon

Versant Capital Management’s Cogent Biosciences COGT Stock Holding History

Versant Capital Management’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$5.44K Hold
170
– – ﹤0.01% 2440
2026
Q2 		$6.58K Sell
170
-11
-6% -$385 ﹤0.01% 2365
2026
Q1 		$6.97K Buy
181
+11
+6% +$406 ﹤0.01% 2282
2025
Q4 		$6.04K Hold
170
– – ﹤0.01% 2178
2025
Q3 		$2.44K Hold
170
– – ﹤0.01% 2378
2025
Q2 		$1.22K Buy
+170
New +$942 ﹤0.01% 2461

Other funds holding COGT

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Emerald Advisers
Emerald Advisers Leola, Pennsylvania $3.64B AUM 71.19% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Emerald Mutual Fund Advisers Trust
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.45B AUM 70.46% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 24.61% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $25.3B AUM 15.9% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Versant Capital Management's COGT Position: Q3 2026 in Review

Versant Capital Management held its Cogent Biosciences (COGT) position steady in Q3 2026 at 170 shares worth $5.44K. The position accounts for ﹤0.01% of the portfolio, ranked #2440.

Versant Capital Management first reported a position in COGT in Q2 2025 and has held it in 6 quarters since. The position peaked at $6.97K in Q1 2026. 99 funds tracked by Wall St. Rank hold COGT as of Q3 2026.

  • Versant Capital Management held 170 shares of Cogent Biosciences worth $5.44K as of Q3 2026.
  • Versant Capital Management left its Cogent Biosciences share count unchanged in Q3 2026.
  • Cogent Biosciences made up ﹤0.01% of Versant Capital Management's portfolio in Q3 2026, its #2440 holding.
  • Versant Capital Management first reported a position in Cogent Biosciences in Q2 2025 and has held it in 6 quarters since.
  • Versant Capital Management's Cogent Biosciences position peaked at $6.97K in Q1 2026.
  • 99 funds tracked by Wall St. Rank held Cogent Biosciences as of Q3 2026.

Based on Versant Capital Management's 13F filing for Q3 2026, filed 2 Oct 2026.